|
Volumn 11, Issue 5, 2003, Pages 593-600
|
Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRHEUMATIC AGENT;
METHOTREXATE;
METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);
THYMIDYLATE SYNTHASE;
ARTICLE;
DOSE RESPONSE;
ENZYMOLOGY;
FEMALE;
GENETIC POLYMORPHISM;
GENETICS;
GENOTYPE;
HUMAN;
JAPAN;
MALE;
METABOLISM;
PROMOTER REGION;
RHEUMATOID ARTHRITIS;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
GENOTYPE;
HUMANS;
JAPAN;
MALE;
METHOTREXATE;
METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);
POLYMORPHISM, GENETIC;
PROMOTER REGIONS (GENETICS);
THYMIDYLATE SYNTHASE;
MLCS;
MLOWN;
|
EID: 0642286407
PISSN: 11073756
EISSN: None
Source Type: Journal
DOI: 10.3892/ijmm.11.5.593 Document Type: Article |
Times cited : (176)
|
References (0)
|